Tzamal Biopharma is an Israeli privately-owned company and a member of the Tzamal Medical Group of companies engages in sourcing, importing, marketing and selling of top-quality pharmaceutical products.
Tzamal Biopharma sells and supplies public & private hospitals, healthcare clinics and all 4 major Sick Funds in Israel a variety of pharmaceutical products for a wide range diseases clinical disciplines including : oncology, haemato-oncology, bone-marrow transplantation, gynecology, cardiology, as well as anti-infective products and more. In addition, our company sells a wide range of community products for general practitioners, family physicians and internists.
With our own clinically trained sales representatives, renowned for in-depth knowledge of the market, we have developed close ties with medical opinion leaders across the country, allowing us to maintain a leading market position and a preferred vendor of top-quality pharmaceutical products.
Our senior management comprises of highly experienced professionals who have gained vast track record in marketing & Selling of innovative pharmaceutical products in the local market, likewise steering and successfully managing market penetration campaigns for newly developed drugs.
Creativity, innovative marketing, and daily promotional activities are key in maintaining our leadership market position.
Shareholder & Managing Director
Mr. Edi Steinberg
Sales & Marketing Manager
Mrs. Osnat Weisbord
Mr. Peter Blau – Responsible pharmacist, QP
Mrs. Hadar Oliar – QPPV, QA
Mrs. Sigal Maimon
Team Leader Product Manager
Mrs. Eti Shimshi